208. Variation in Clinical Practice and Attitudes in the Management of Fever and Neutropenia in Patients With Hematologic Malignancy: A Survey of Cancer Centers Across the United S...

por Aitken, Samuel L, Aitken, Samuel L, Barreto, Jason N, Nagel, Jerod, Seo, Susan K, Seo, Susan K, Liu, Catherine
Publicado 2020

1291. Safety of Isavuconazole Compared with Voriconazole as Primary Antifungal Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients

por Bogler, Yael, Stern, Anat, Su, Yiqi, Lee, Yeon Joo, Seo, Susan K, Seo, Susan K, Giralt, Sergio, Perales, Miguel-Angel, Neofytos, Dionysios, Papanicolaou, Genovefa
Publicado 2020

2579. Pneumonia Severity Index and CURB-65 scoring for the evaluation of community associated pneumonia in patients with cancer at a major cancer center

por Gali, Varshini, Lee, Yeon Joo, Jani, Krupa, Kaltsas, Anna, Seo, Susan K, Cintron, Melvili
Publicado 2023

Antimicrobial de-escalation in septic cancer patients: is it safe to back down?

por Paskovaty, Alla, Pastores, Stephen M., Gedrimaite, Zivile, Kostelecky, Natalie, Riedel, Elyn R., Seo, Susan K.
Publicado 2015

434 Prevalence, Risk Factors, and Outcomes of Bacteremia Caused by Carbapenem-resistant Enterobacteriaceae in Neutropenic Patients with Hematologic Malignancies

por Satlin, Michael J., Cohen, Nina, Ma, Kevin C., Gedrimaite, Zivile, Walsh, Thomas J., Seo, Susan K.
Publicado 2014

Cytokine Release Syndrome Grade as a Predictive Marker for Infections in Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Treated With Chimeric Antigen Rece...

por Park, Jae H, Romero, F Andres, Taur, Ying, Sadelain, Michel, Brentjens, Renier J, Hohl, Tobias M, Seo, Susan K
Publicado 2018

Variation in Clinical Practice and Attitudes on Antibacterial Management of Fever and Neutropenia in Patients With Hematologic Malignancy: A Survey of Cancer Centers Across the Uni...

por Barreto, Jason N, Aitken, Samuel L, Krantz, Elizabeth M, Nagel, Jerod L, Dadwal, Sanjeet S, Seo, Susan K, Liu, Catherine
Publicado 2022

Analyzing Adherence to the 2016 Infectious Diseases Society of America Guidelines for Candidemia in Cancer Patients

por Lehmann, Dena M, Cohen, Nina, Lin, I-Hsin, Alexander, Shane, Kathuria, Ritu, Kerpelev, Marina, Taur, Ying, Seo, Susan K
Publicado 2022

1742. Kinetics of CMV Viremia with Letermovir Prophylaxis in the First 100 Days post Hematopoietic Cell Transplantation (HCT): A Single-center Experience

por Zavras, Phaedon D, Stern, Anat, Su, Yiqi, Fang, Jiaqi, Giralt, Sergio, Perales, Miguel, Maloy, Molly, Seo, Susan K, Papanicolaou, Genovefa
Publicado 2019

Developing Interactive Antimicrobial Stewardship and Infection Prevention Curricula for Diverse Learners: A Tailored Approach

por Nori, Priya, Madaline, Theresa, Munjal, Iona, Bhar, Shubha, Guo, Yi, Seo, Susan K., Porrovecchio, Andrea, Gancher, Elizabeth, Nosanchuk, Joshua, Pirofski, Liise-anne, Ostrowsky, Belinda
Publicado 2017

Extended-duration letermovir prophylaxis for cytomegalovirus infection after cord blood transplantation in adults

por Politikos, Ioannis, Lau, Carmen, Devlin, Sean M., Quach, Sean, Lin, Andrew, Perales, Miguel-Angel, Shah, Gunjan L., Seo, Susan K., Papanicolaou, Genovefa A., Barker, Juliet N.
Publicado 2022

Toxoplasma Encephalitis in Atypical Hosts at an Academic Cancer Center

por Morjaria, Sejal, Epstein, David J., Romero, Fabian A., Taur, Ying, Seo, Susan K., Papanicolaou, Genovefa A., Hatzoglou, Vaios, Rosenblum, Marc, Perales, Miguel-Angel, Scordo, Michael, Kaltsas, Anna
Publicado 2016

Diagnosis of Extrapulmonary Legionellosis in Allogeneic Hematopoietic Cell Transplant Recipients by Direct 16S Ribosomal Ribonucleic Acid Sequencing and Matrix-Assisted Laser Desor...

por Franco-Garcia, Alexandra, Varughese, Tilly A, Lee, Yeon Joo, Papanicolaou, Genovefa, Rosenblum, Marc K, Hollmann, Travis J, Koehne, Guenther, Boulad, Farid, Babady, N Esther, Tang, Yi-Wei, Seo, Susan K
Publicado 2017

939 Electronic Mail (email) Reminders as an Alternative to Directly Observed Therapy (DOT) for the Treatment of Latent Tuberculosis Infection (LTBI) using 12 weeks of Rifapentine a...

por Lacaille, Sherard N.J., Del-Castillo-Garcia, Maria, Bianchi, Anabella Lucca-, Morjaria, Sejal M., Palomino-Guillen, Paola M., Eisenstein, Cynthia, Murillo, Susan, Seo, Susan K., Brown, Arthur E., Schneider, William J.
Publicado 2014

SHEA statement on antibiotic stewardship in hospitals during public health emergencies

por Barlam, Tamar F., Al Mohajer, Mayar, Al-Tawfiq, Jaffar A., Auguste, Antonie J., Cunha, Cheston B., Forrest, Graeme N., Gross, Alan E., Lee, Rachael A., Seo, Susan K., Suh, Kathryn N., Volk, Stacy, Schaffzin, Joshua K.
Publicado 2022

Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients

por Laracy, Justin C., Yan, Judy, Steiger, Samantha N., Tan, Carrie A., Cohen, Nina, Robilotti, Elizabeth V., Fender, Jerome, Cohen, Sara, Korde, Neha, Lee-Teh, Melissa, Noy, Ariela, Oved, Joseph H., Roeker, Lindsey E., Shah, Gunjan, Babady, N. Esther, Kamboj, Mini, Seo, Susan K.
Publicado 2023

1826. Impact of Rapid Diagnostics and Ceftazidime–Avibactam on Mortality after Bacteremia Caused by Carbapenem-Resistant Enterobacteriaceae

por Satlin, Michael J, Chen, Liang, Weston, Gregory, Gomez-Simmonds, Angela, Bhowmick, Tanaya, Seo, Susan K, Sperber, Steven, Kim, Angela, Eilertson, Brandon, Jenkins, Stephen, Levi, Michael, Uhlemann, Anne-Catrin, Weinstein, Melvin P, Tang, Yi-Wei, Hong, Tao, Juretschko, Stefan, Walsh, Thomas J, Westblade, Lars, Kreiswirth, Barry
Publicado 2019

Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma

por Wudhikarn, Kitsada, Palomba, M. Lia, Pennisi, Martina, Garcia-Recio, Marta, Flynn, Jessica R., Devlin, Sean M., Afuye, Aishat, Silverberg, Mari Lynne, Maloy, Molly A., Shah, Gunjan L., Scordo, Michael, Dahi, Parastoo B., Sauter, Craig S., Batlevi, Connie L., Santomasso, Bianca D., Mead, Elena, Seo, Susan K., Perales, Miguel-Angel
Publicado 2020

Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies

por Stuver, Robert, Shah, Gunjan L., Korde, Neha S., Roeker, Lindsey E., Mato, Anthony R., Batlevi, Connie L., Chung, David J., Doddi, Sital, Falchi, Lorenzo, Gyurkocza, Boglarka, Hamilton, Audrey, Lin, Ya-Hui, Jakubowski, Ann A., Joffe, Erel, Landau, Heather L., Lin, Richard J., Mailankody, Sham, Palomba, M. Lia, Park, Jae H., Perales, Miguel-Angel, Ponce, Doris M., Ramanathan, Lakshmi V., Salles, Gilles A., Scordo, Michael, Seo, Susan K., Shah, Urvi A., Stein, Eytan M., Straus, David, Usmani, Saad Z., Young, James W., Zelenetz, Andrew D., Noy, Ariela, Vardhana, Santosha A.
Publicado 2022